论文信息 - Phase I-II trial of intramuscularly administered bleomycin. - 字舞流文

Phase I-II trial of intramuscularly administered bleomycin.

S. Pocock | P. Carbone | W. Regelson | H. Lerner | E. Savlov | J. Colsky | M. Cohen

[1] V. Devita,et al. High dose intravenous bleomycin in the treatment of advanced lymphomas. , 1975, European journal of cancer.

[2] S. Carter,et al. A clinical review of bleomycin—a new antineoplastic agent , 1973, Cancer.

[3] M. Zelen. Keynote address on biostatistics and data retrieval. , 1973, Cancer chemotherapy reports. Part 3.

[4] J. Smith,et al. Bleomycin, an antitumor antibiotic. Clinical experience in 274 patients. , 1972, Annals of internal medicine.

[5] V. Devita,et al. Clinical study with bleomycin: Tolerance to twice weekly dosage , 1972, Cancer.

[6] R. Rudders. Treatment of advanced malignant lymphomas with bleomycin. , 1972, Blood.

[7] G. Bonadonna,et al. Clinical trials with bleomycin in lymphomas and in solid tumors. , 1972, European journal of cancer.